Gilead Sciences Inc. (GILD)

Statement of Comprehensive Income

Difficulty: Beginner

Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

Gilead Sciences Inc., consolidated statement of comprehensive income

US$ in millions

12 months ended	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Net income	5,460	4,644	13,488	18,106	12,059
Net foreign currency translation gain (loss), net of tax	(38)	(47)	177	9	(9)
Available-for-sale securities, net change	47	210	—	(28)	—
Cash flow hedges, net change	199	(276)	13	(194)	434
Other comprehensive income (loss)	208	(113)	190	(213)	425
Comprehensive income	5,668	4,531	13,678	17,893	12,484
Comprehensive (income) loss attributable to noncontrolling interest	(5)	(16)	13	2	42
Comprehensive income attributable to Gilead	5,663	4,515	13,691	17,895	12,526

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

Comprehensive income item	Description	The company
Net income attributable to Gilead	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	Gilead Sciences Inc.’s net income attributable to Gilead declined from 2016 to 2017 but then slightly increased from 2017 to 2018.
Comprehensive income attributable to Gilead	Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.	Gilead Sciences Inc.’s comprehensive income attributable to Gilead declined from 2016 to 2017 but then slightly increased from 2017 to 2018.